4882 — Perseus Proteomics Balance Sheet
0.000.00%
Last trade - 00:00
- ¥4bn
- ¥2bn
- ¥94m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,100 | 482 | 1,069 | 3,215 | 2,445 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 197 | 37.3 | 30.7 | 45.4 | 51.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,350 | 538 | 1,109 | 3,291 | 2,515 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,360 | 548 | 1,119 | 3,301 | 2,567 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 32.5 | 62 | 34.9 | 148 | 111 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 32.5 | 62 | 34.9 | 148 | 170 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,328 | 486 | 1,084 | 3,152 | 2,397 |
Total Liabilities & Shareholders' Equity | 1,360 | 548 | 1,119 | 3,301 | 2,567 |
Total Common Shares Outstanding |